Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center

Military Medicine

Volumn 173, Issue 6, 2008, Pages 604-608

  Perkins, Dana ^a   Hogue, Jacob S ^a   Fairchok, Mary ^a   Braun, LoRanée ^a   Viscount, Helen B ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; NITROFURANTOIN; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; EPSILOMETER TEST; HEALTH CENTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; SCREENING;

EID: 45749130546     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.173.6.604     Document Type: Article

References (20)

1. Seybold U, Kourbatova EV, Johnson JG, et al: Emergence of community-associated methicillin-resistant S. aureus USA 300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42: 647-56.
2. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee: Management of multidrug-resistant organisms in healthcare settings, 2006; Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/ mdroGuideline2006.pdf; accessed August 27, 2007.
3. Casewell MW, Hill RL: Mupirocin: a promising new topical antimicrobial agent. J Antimicrob Chemother 1987; 19: 1-5.
4. Baird D, Coia J: Mupirocin-resistant Staphylococcus aureus. Lancet 1987; 2: 387-8.
5. Kavi J, Andrews JM, Wise R: Mupirocin-resistant Staphylococcus aureus. Lancet 1987; 2: 1472-3.
6. Janssen DA, Zarins LT, Schaberg DR, Bradley SF, Terpenning MS, Kauffman CA: Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37: 2003-6.
7. Chaves F, Garcia-Martinez J, de Miguel S, Otero JR: Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples. J Clin Microbiol 2004; 42: 822-4.
8. Hodgson JE, Curnock SP, Dyte KG, Morris R, Sylvester DR, Gross MS: Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob Agents Chemother 1994; 38: 1205-8.
9. Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17: 811-6.
10. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, Jones ME: The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998; 42: 489-95.
11. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Regan DR, Sarubbi FA: The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs Hospital. Infect Control Hosp Epidemiol 2000; 21: 459-64.
12. Jones PG, Sura T, Harris M, Strother A: Mupirocin resistance in clinical isolates of Staphylococcus aureus. Infect Control Hosp Epidemiol 2003; 24: 300-1.
13. Yun HJ, Lee SW, Yoon GM, et al: Prevalence and mechanisms of low-and high-level mupirocin resistance in staphylococci isolated from a Korean Hospital. J Antimicrob Chemother 2003; 51: 619-23.
14. Petinaki E, Spiliopoulou I, Kontos F, et al: Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. J Antimicrob Chemother 2004; 53: 105-8.
15. Walker E, Levy F, Shorman M, David G, Abdalla J, Sarubbi FA: A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. J Clin Microbiol 2004; 42: 2792-5.
16. Perez-Roth E, Claverie-Martin F, Villar J, Mendez-Alvarez S: Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. J Clin Microbiol 2001; 39: 4037-41.
17. Desjardins M, Guibord C, Lalonde B, Toye B, Ramotar K: Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J Clin Microbiol 2006; 44: 1219-23.
18. Jones JC, Rogers TJ, Brookmeyer P, et al: Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. CID 2007; 45: 541-7.
19. Singh K, Malathum K, Murray BE: In vitro activities of a new ketolide, ABT-773, against multi-drug-resistant Gram-positive cocci Antimicrob Agents Chemother 2001; 45; 3640-3.
20. Livermore DM: Tigecycline: what is it, and where should it be used? J Antimicrob Chemother 2005; 56: 611-4.